$BCBP
BCB BANCORP INC

2024 Q1 Form 10-K Financial Statement

#000122845424000003 Filed on March 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $49.29M $188.4M
YoY Change 16.37% 43.3%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $457.0K $478.0K $1.978M
YoY Change -4.39% -6.46% -11.93%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $26.14M $84.30M
YoY Change 75.67% 381.81%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $8.326M $8.655M $41.46M
YoY Change -26.52% -44.89% -34.31%
Income Tax $2.460M $2.593M $11.97M
% Of Pretax Income 29.55% 29.96% 28.88%
Net Earnings $5.432M $5.880M $28.78M
YoY Change -31.53% -50.59% -35.73%
Net Earnings / Revenue 11.02% 15.28%
Basic Earnings Per Share $0.32 $1.71
Diluted Earnings Per Share $0.32 $0.35 $1.70
COMMON SHARES
Basic Shares Outstanding 16.96M 16.85M 16.87M
Diluted Shares Outstanding 16.94M 16.93M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $352.4M $279.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $24.93M $25.99M $25.99M
YoY Change -1.14% 8.17% 8.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $9.223M $9.093M $9.093M
YoY Change -36.21% -48.59% -48.59%
Other Assets $17.56M $18.21M $18.21M
YoY Change 15.66% 10.64% 10.64%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.849B $3.832B $3.832B
YoY Change 2.29% 8.07% 8.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $12.58M $13.32M $13.32M
YoY Change -18.51% -3.93% -3.93%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.58M $13.32M $13.32M
YoY Change -18.51% -3.93% -3.93%
LONG-TERM LIABILITIES
Long-Term Debt $37.62M $37.62M $37.62M
YoY Change 0.15% 0.31% 0.31%
Other Long-Term Liabilities $14.25M $15.51M $15.51M
YoY Change 11.11% 59.85% 59.85%
Total Long-Term Liabilities $51.88M $53.14M $53.14M
YoY Change 2.94% 12.55% 12.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.58M $13.32M $13.32M
Total Long-Term Liabilities $51.88M $53.14M $53.14M
Total Liabilities $3.529B $3.518B $3.518B
YoY Change 1.84% 8.09% 8.09%
SHAREHOLDERS EQUITY
Retained Earnings $138.6M $135.9M
YoY Change 12.61% 18.09%
Common Stock $199.7M $198.9M
YoY Change 1.28% 1.41%
Preferred Stock $27.73M $25.04M
YoY Change 32.04% 19.24%
Treasury Stock (at cost) $38.35M $38.35M
YoY Change 3.39% 11.05%
Treasury Stock Shares
Shareholders Equity $320.1M $314.1M $314.1M
YoY Change
Total Liabilities & Shareholders Equity $3.849B $3.832B $3.832B
YoY Change 2.29% 8.07% 8.07%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $5.432M $5.880M $28.78M
YoY Change -31.53% -50.59% -35.73%
Depreciation, Depletion And Amortization $457.0K $478.0K $1.978M
YoY Change -4.39% -6.46% -11.93%
Cash From Operating Activities $8.288M $658.0K $35.16M
YoY Change -49.51% -91.9% -14.02%
INVESTING ACTIVITIES
Capital Expenditures $144.0K $227.0K $4.527M
YoY Change 89.47% -23.57% 773.94%
Acquisitions
YoY Change
Other Investing Activities $52.05M $15.61M -$228.8M
YoY Change -128.04% -105.9% -69.93%
Cash From Investing Activities $51.91M $15.38M -$233.3M
YoY Change -127.95% -105.81% -69.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.73M 11.53M 248.3M
YoY Change -93.67% -95.65% -53.87%
NET CHANGE
Cash From Operating Activities 8.288M 658.0K 35.16M
Cash From Investing Activities 51.91M 15.38M -233.3M
Cash From Financing Activities 12.73M 11.53M 248.3M
Net Change In Cash 72.93M 27.56M 50.16M
YoY Change 129.93% 230.7% -127.52%
FREE CASH FLOW
Cash From Operating Activities $8.288M $658.0K $35.16M
Capital Expenditures $144.0K $227.0K $4.527M
Free Cash Flow $8.144M $431.0K $30.63M
YoY Change -50.15% -94.5% -24.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 bcbp Reclassification Adjustment For Gains Realized In Income
ReclassificationAdjustmentForGainsRealizedInIncome
CY2022 bcbp Reclassification Adjustment For Gains Realized In Income
ReclassificationAdjustmentForGainsRealizedInIncome
CY2023 bcbp Reclassification Adjustment For Gains Realized In Income
ReclassificationAdjustmentForGainsRealizedInIncome
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001228454
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
CY2021 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-50275
CY2023 dei Entity Registrant Name
EntityRegistrantName
BCB BANCORP, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NJ
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0065262
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
104-110 Avenue C
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Bayonne
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07002
CY2023 dei City Area Code
CityAreaCode
800
CY2023 dei Local Phone Number
LocalPhoneNumber
680-6872
CY2023 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Trading Symbol
TradingSymbol
BCBP
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
172200000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16957391
CY2023 dei Auditor Name
AuditorName
Wolf & Company, P.C
CY2023 dei Auditor Firm
AuditorFirmId
392
CY2023 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2023Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
16597000
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
11520000
CY2023Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
262926000
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
217839000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
279523000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
229359000
CY2023Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2022Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
87769000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
91715000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
9093000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17686000
CY2023Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
1287000
CY2022Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
658000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
32373000
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
3279708000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
3045331000
CY2023Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
24917000
CY2022Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
20113000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13057000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10508000
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
16072000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
13455000
CY2022Q4 us-gaap Other Real Estate
OtherRealEstate
75000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
18213000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
16462000
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5253000
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5382000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12935000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13520000
CY2023Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
73407000
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
71656000
CY2023Q4 us-gaap Other Assets
OtherAssets
10428000
CY2022Q4 us-gaap Other Assets
OtherAssets
9538000
CY2023Q4 us-gaap Assets
Assets
3832397000
CY2022Q4 us-gaap Assets
Assets
3546193000
CY2023Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
536264000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
613910000
CY2023Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2442816000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
2197697000
CY2023Q4 us-gaap Deposits
Deposits
2979080000
CY2022Q4 us-gaap Deposits
Deposits
2811607000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
472811000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
382261000
CY2023Q4 us-gaap Subordinated Debt
SubordinatedDebt
37624000
CY2022Q4 us-gaap Subordinated Debt
SubordinatedDebt
37508000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13315000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13859000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
15512000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
9704000
CY2023Q4 us-gaap Liabilities
Liabilities
3518342000
CY2022Q4 us-gaap Liabilities
Liabilities
3254939000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2528
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2528
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2124
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2124
CY2023Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
25043000
CY2022Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
21003000
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20138294
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19898197
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16904323
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16930979
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
198923000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
196164000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
135927000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
115109000
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
104062000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
113945000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
97393000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7491000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6491000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3233971
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2967218
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
38347000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
34531000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
314055000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
291254000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3832397000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3546193000
CY2023 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
169559000
CY2022 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
123577000
CY2021 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
107660000
CY2023 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
880000
CY2022 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
564000
CY2021 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
680000
CY2023 us-gaap Interest Income Other
InterestIncomeOther
4226000
CY2022 us-gaap Interest Income Other
InterestIncomeOther
4167000
CY2021 us-gaap Interest Income Other
InterestIncomeOther
3274000
CY2023 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
13695000
CY2022 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
3133000
CY2021 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
959000
CY2023 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
188360000
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
131441000
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
112573000
CY2023 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
16915000
CY2022 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
5283000
CY2021 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
4335000
CY2023 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
620000
CY2022 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
449000
CY2021 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
505000
CY2023 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
39157000
CY2022 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
6889000
CY2021 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
6160000
CY2023 us-gaap Interest Expense Deposits
InterestExpenseDeposits
56692000
CY2022 us-gaap Interest Expense Deposits
InterestExpenseDeposits
12621000
CY2021 us-gaap Interest Expense Deposits
InterestExpenseDeposits
11000000
CY2023 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
27606000
CY2022 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
4875000
CY2021 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
4180000
CY2023 us-gaap Interest Expense
InterestExpense
84298000
CY2022 us-gaap Interest Expense
InterestExpense
17496000
CY2021 us-gaap Interest Expense
InterestExpense
15180000
CY2023 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
6104000
CY2022 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
-3075000
CY2021 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
3855000
CY2023 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
97958000
CY2022 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
117020000
CY2021 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
93538000
CY2023 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
5334000
CY2022 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
4816000
CY2021 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
3972000
CY2023 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1751000
CY2022 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
2671000
CY2021 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
2952000
CY2023 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
36000
CY2022 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
129000
CY2021 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
667000
CY2021 bcbp Gain Loss On Sale Of Impaired Loans Held In Portfolio
GainLossOnSaleOfImpairedLoansHeldInPortfolio
-64000
CY2023 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
77000
CY2021 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
11000
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
371000
CY2023 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-3361000
CY2022 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-6269000
CY2021 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
147000
CY2023 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
251000
CY2022 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
248000
CY2021 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
639000
CY2023 us-gaap Noninterest Income
NoninterestIncome
4088000
CY2022 us-gaap Noninterest Income
NoninterestIncome
1595000
CY2021 us-gaap Noninterest Income
NoninterestIncome
8695000
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
30827000
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
28021000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
26410000
CY2023 us-gaap Occupancy Net
OccupancyNet
10340000
CY2022 us-gaap Occupancy Net
OccupancyNet
10627000
CY2021 us-gaap Occupancy Net
OccupancyNet
11360000
CY2023 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
6968000
CY2022 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
6033000
CY2021 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
6024000
CY2023 us-gaap Professional Fees
ProfessionalFees
2735000
CY2022 us-gaap Professional Fees
ProfessionalFees
3766000
CY2021 us-gaap Professional Fees
ProfessionalFees
1919000
CY2023 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
1083000
CY2022 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
1253000
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
1043000
CY2023 bcbp Regulatory Assessments
RegulatoryAssessments
3585000
CY2022 bcbp Regulatory Assessments
RegulatoryAssessments
1243000
CY2021 bcbp Regulatory Assessments
RegulatoryAssessments
1310000
CY2023 us-gaap Advertising Expense
AdvertisingExpense
1348000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
941000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
554000
CY2023 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
7000
CY2022 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
10000
CY2021 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
35000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1597000
CY2023 us-gaap Other Noninterest Expense
OtherNoninterestExpense
3698000
CY2022 us-gaap Other Noninterest Expense
OtherNoninterestExpense
3611000
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
3723000
CY2023 us-gaap Noninterest Expense
NoninterestExpense
60591000
CY2022 us-gaap Noninterest Expense
NoninterestExpense
55505000
CY2021 us-gaap Noninterest Expense
NoninterestExpense
53975000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
41455000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63110000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48258000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11972000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17531000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14018000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
29483000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
45579000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
34240000
CY2023 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
702000
CY2022 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
796000
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1160000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
28781000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
44783000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
33080000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.71
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.64
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.70
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.58
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.92
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16870000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16969000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17063000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16932000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17349000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17239000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
29483000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
45579000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
34240000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1493000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-10327000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-242000
CY2023 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-1493000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-10327000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-242000
CY2023 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-355000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-2560000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-60000
CY2023 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1138000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-7767000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-182000
CY2023 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
-131000
CY2022 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
-212000
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
-2165000
CY2023 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
-7000
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
64000
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
650000
CY2023 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
138000
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
148000
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
1515000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7619000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1333000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
28483000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37960000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
35573000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
249211000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
34240000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1333000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3200000
CY2021 bcbp Stock Issued During Period Shares Stock Option Exercised Excluding Cashless Exercises
StockIssuedDuringPeriodSharesStockOptionExercisedExcludingCashlessExercises
39291
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
287000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
417000
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1160000
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2021Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2021Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2021Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9775000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
478000
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
301024
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4207000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
274024000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
45579000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7619000
CY2022 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
14730000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6810000
CY2022 bcbp Stock Issued During Period Shares Stock Option Exercised Excluding Cashless Exercises
StockIssuedDuringPeriodSharesStockOptionExercisedExcludingCashlessExercises
72846
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
220000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1132000
CY2022 us-gaap Dividends Preferred Stock
DividendsPreferredStock
796000
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.64
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10379000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
419000
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
198976
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3406000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
291254000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
29483000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000
CY2023 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
11230000
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15270000
CY2023 bcbp Stock Issued During Period Shares Stock Option Exercised Excluding Cashless Exercises
StockIssuedDuringPeriodSharesStockOptionExercisedExcludingCashlessExercises
51372
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
418000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
593000
CY2023 us-gaap Dividends Preferred Stock
DividendsPreferredStock
702000
CY2023 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.64
CY2023 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10440000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1355000
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
266753
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3816000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
314055000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
29483000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
45579000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
34240000
CY2023 us-gaap Depreciation Nonproduction
DepreciationNonproduction
1978000
CY2022 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2246000
CY2021 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2989000
CY2023 bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
2533000
CY2022 bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
1607000
CY2021 bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
767000
CY2023 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
6104000
CY2022 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
-3075000
CY2021 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
3855000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2537000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1007000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-975000
CY2023 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
2964000
CY2022 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
6608000
CY2021 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
26159000
CY2023 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
2371000
CY2022 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
7031000
CY2021 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
29404000
CY2023 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
36000
CY2022 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
129000
CY2021 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
667000
CY2021 us-gaap Other Real Estate Valuation Adjustments
OtherRealEstateValuationAdjustments
-6000
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
371000
CY2023 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-3361000
CY2022 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-6269000
CY2021 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
147000
CY2023 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
77000
CY2021 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
11000
CY2021 bcbp Gain Loss On Sale Of Impaired Loans Held In Portfolio
GainLossOnSaleOfImpairedLoansHeldInPortfolio
-64000
CY2023 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1751000
CY2022 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
2671000
CY2021 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
2952000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
593000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1132000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
417000
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
2617000
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
4272000
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-3741000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
890000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1552000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1025000
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2704000
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2022000
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-412000
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1969000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2469000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2613000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35158000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40889000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45893000
CY2023 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
14745000
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
10102000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
32597000
CY2023 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
12498000
CY2022 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
27468000
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
26141000
CY2023 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
5232000
CY2022 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1232000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
742000
CY2021 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
8500000
CY2022 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
3500000
CY2023 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
152000
CY2021 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
425000
CY2021 bcbp Proceeds From Bulk Sale Of Impaired Loans
ProceedsFromBulkSaleOfImpairedLoans
3442000
CY2023 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
231622000
CY2022 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
734321000
CY2021 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
15148000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4527000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
518000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
325000
CY2023 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
4804000
CY2022 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
14029000
CY2021 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-5240000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-233322000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-761502000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7668000
CY2023 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
167473000
CY2022 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
250205000
CY2021 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
243352000
CY2023 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
400000000
CY2022 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
150000000
CY2021 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
10000000
CY2023 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
150000000
CY2021 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
130000000
CY2023 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
-160000000
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
160000000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3816000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3406000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4207000
CY2023 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10440000
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10379000
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9775000
CY2023 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
702000
CY2022 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
796000
CY2021 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1160000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1355000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
419000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
478000
CY2023 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
15270000
CY2022 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
6810000
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
3200000
CY2023 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
11230000
CY2022 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
14730000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
418000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
220000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
287000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
248328000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
538343000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
112175000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
50164000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-182270000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
150400000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
229359000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411629000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261229000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
279523000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
229359000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411629000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18027000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18804000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12020000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
81594000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
15475000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
15592000
CY2021 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
81000
CY2023 bcbp Number Of Locations
NumberOfLocations
28
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
0
CY2023Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
0
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Concentration of Risk</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.01in;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.01in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Financial instruments which potentially subject the Company and its subsidiaries to concentrations of credit risk consist of cash and cash equivalents, investment and mortgage-backed securities and loans.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.01in;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cash and cash equivalents include amounts placed with highly rated financial institutions. Securities include securities backed by the U.S. Government and other highly rated instruments. The Bank’s lending activity is primarily concentrated in loans collateralized by real estate in the State of New Jersey and the New York metropolitan area as a result, credit risk related to loans is broadly dependent on the real estate market and general economic conditions in the area.</span>
CY2023Q4 bcbp Other Real Estate Owned Number Of Properties
OtherRealEstateOwnedNumberOfProperties
0
CY2022Q4 bcbp Other Real Estate Owned Number Of Properties
OtherRealEstateOwnedNumberOfProperties
1
CY2022Q4 us-gaap Other Real Estate
OtherRealEstate
75000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
29483000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
45579000
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6476
CY2021 us-gaap Net Income Loss
NetIncomeLoss
34240000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
28781000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16870000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.71
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
44783000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16969000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.64
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
33080000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17063000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
62000
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
380000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
176000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
28781000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16932000
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.70
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
44783000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17349000
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.58
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
33080000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17239000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.92
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
74009000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
9474000
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
79325000
CY2021 bcbp Operating Leases Rent Expense Monthly Amount
OperatingLeasesRentExpenseMonthlyAmount
13750
CY2022 bcbp Operating Leases Rent Expense Monthly Amount
OperatingLeasesRentExpenseMonthlyAmount
13750
CY2023 bcbp Operating Leases Rent Expense Monthly Amount
OperatingLeasesRentExpenseMonthlyAmount
13750
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
9100000
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
17700000
CY2023 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-3361000
CY2022 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-6269000
CY2021 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
147000
CY2023 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-24000
CY2022 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-59000
CY2023 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-3337000
CY2022 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-6210000
CY2021 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
147000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
97149000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
192000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9572000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
87769000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
99602000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7887000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
91715000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
5316000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
98000
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
9572000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
72960000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
5227000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
17456000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2660000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
90416000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
7887000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3317402000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3082418000
CY2023Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
4086000
CY2022Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
4714000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
32373000
CY2023Q4 bcbp Total Deductions From Gross Loans
TotalDeductionsFromGrossLoans
37694000
CY2022Q4 bcbp Total Deductions From Gross Loans
TotalDeductionsFromGrossLoans
37087000
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
3279708000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
3045331000
CY2023Q4 bcbp Participation Interest In Loans Originated
ParticipationInterestInLoansOriginated
135400000
CY2022Q4 bcbp Participation Interest In Loans Originated
ParticipationInterestInLoansOriginated
159300000
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
26265000
CY2021Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
31696000
CY2023 us-gaap Loans And Leases Receivable Related Parties Additions
LoansAndLeasesReceivableRelatedPartiesAdditions
2882000
CY2023 us-gaap Loans And Leases Receivable Related Parties Proceeds
LoansAndLeasesReceivableRelatedPartiesProceeds
939000
CY2022 us-gaap Loans And Leases Receivable Related Parties Proceeds
LoansAndLeasesReceivableRelatedPartiesProceeds
5431000
CY2023Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
28208000
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
26265000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
32373000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
805000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
101000
CY2023 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
6104000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
4229000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
29379000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33608000
CY2023Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
54019000
CY2023Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3263383000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3317402000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37119000
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2095000
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
424000
CY2022 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
-3075000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
32373000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
2784000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
29589000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
32373000
CY2022Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
28272000
CY2022Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3054146000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3082418000
CY2023Q4 bcbp Financingreceivablenonaccrualwithallowance
Financingreceivablenonaccrualwithallowance
6940000
CY2023Q4 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
11843000
CY2023Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
18783000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
5109000
CY2023 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
1900000
CY2022 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
1000000.0
CY2023 bcbp Nonaccrual Loans Interest Income Cash Basis Method
NonaccrualLoansInterestIncomeCashBasisMethod
314000000000
CY2022 bcbp Nonaccrual Loans Interest Income Cash Basis Method
NonaccrualLoansInterestIncomeCashBasisMethod
1600000
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2023Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
19901000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
24975000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
8371000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
13539000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
2784000
CY2022Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
28272000
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
38514000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
2784000
CY2022 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
27282000
CY2022 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
1334000
CY2022 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
13026000
CY2022 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
480000
CY2022 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
40308000
CY2022 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
1814000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3317402000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3082418000
CY2023Q4 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
281000000
CY2023Q4 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
959372000
CY2023Q4 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
333030000
CY2023Q4 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
276923000
CY2023Q4 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
72067000
CY2023Q4 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
1021468000
CY2023Q4 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
372777000
CY2023Q4 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
765000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
3317402000
CY2023 us-gaap Financing Receivable Year One Originated Current Fiscal Year Writeoff
FinancingReceivableYearOneOriginatedCurrentFiscalYearWriteoff
500000
CY2023 us-gaap Financing Receivable Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff
FinancingReceivableYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff
305000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
805000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32606000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29822000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19549000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19314000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13057000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10508000
CY2023 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2000000.0
CY2022 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2200000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
16072000
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
13455000
CY2023Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
536264000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
613910000
CY2023Q4 bcbp Demand Deposit Accounts Interest Bearing
DemandDepositAccountsInterestBearing
564912000
CY2022Q4 bcbp Demand Deposit Accounts Interest Bearing
DemandDepositAccountsInterestBearing
757615000
CY2023Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
370934000
CY2022Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
305556000
CY2023Q4 us-gaap Demand Deposit Accounts
DemandDepositAccounts
1472110000
CY2022Q4 us-gaap Demand Deposit Accounts
DemandDepositAccounts
1677081000
CY2023Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
284273000
CY2022Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
329752000
CY2023Q4 us-gaap Time Deposits
TimeDeposits
1222697000
CY2022Q4 us-gaap Time Deposits
TimeDeposits
804774000
CY2023Q4 us-gaap Deposits
Deposits
2979080000
CY2022Q4 us-gaap Deposits
Deposits
2811607000
CY2023Q4 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
341900000
CY2022Q4 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
207700000
CY2023Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
87300000
CY2023Q4 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
1199120000
CY2023Q4 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
17134000
CY2023Q4 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
3569000
CY2023Q4 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
1785000
CY2023Q4 us-gaap Time Deposit Maturities After Year Five
TimeDepositMaturitiesAfterYearFive
1089000
CY2023Q4 us-gaap Time Deposits
TimeDeposits
1222697000
CY2023Q4 us-gaap Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
505400000
CY2022Q4 us-gaap Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
335000000.0
CY2023Q4 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
35000000.0
CY2022Q4 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
0
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
60000000
CY2023 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
60941000
CY2022 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
1313000
CY2023 us-gaap Shortterm Debt Maximum Monthend Outstanding Amount
ShorttermDebtMaximumMonthendOutstandingAmount
350000000
CY2022 us-gaap Shortterm Debt Maximum Monthend Outstanding Amount
ShorttermDebtMaximumMonthendOutstandingAmount
87000000
CY2023Q4 bcbp Short Term Debt Average Interest Rate
ShortTermDebtAverageInterestRate
0.0525
CY2022Q4 bcbp Short Term Debt Average Interest Rate
ShortTermDebtAverageInterestRate
0.0313
CY2022Q4 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.0461
CY2023Q4 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate
FederalHomeLoanBankAdvancesWeightedAverageInterestRate
0.0421
CY2023Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
472811
CY2022Q4 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate
FederalHomeLoanBankAdvancesWeightedAverageInterestRate
0.0407
CY2022Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
322261000
CY2023 bcbp Net Of Unamortized Prepayment Penalties
NetOfUnamortizedPrepaymentPenalties
988000
CY2022 bcbp Federal Home Loan Bank Advances Unamortized Prepayment Penalties
FederalHomeLoanBankAdvancesUnamortizedPrepaymentPenalties
1500000
CY2021 bcbp Federal Home Loan Bank Advances Unamortized Prepayment Penalties
FederalHomeLoanBankAdvancesUnamortizedPrepaymentPenalties
2100000
CY2022Q4 us-gaap Debt Securities Trading Restricted
DebtSecuritiesTradingRestricted
0
CY2023Q4 us-gaap Debt Securities Trading Restricted
DebtSecuritiesTradingRestricted
0
CY2023 bcbp Maximum Ratio Of Debt To Total Assets Under Debt Covenant
MaximumRatioOfDebtToTotalAssetsUnderDebtCovenant
0.500
CY2023Q4 bcbp Maximum Total Debt Under Debt Covenant
MaximumTotalDebtUnderDebtCovenant
1916000000
CY2023 bcbp Maximum Ratio Of Debt To Total Assets Under Debt Covenant
MaximumRatioOfDebtToTotalAssetsUnderDebtCovenant
0.500
CY2018Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
33500000
CY2023Q4 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses After Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
580000
CY2022Q4 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses After Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
559000
CY2021Q4 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses After Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
707000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
809495
CY2023 bcbp Estimated Long Term Inflation Rate
EstimatedLongTermInflationRate
0.030
CY2023Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
369000
CY2023Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
376000
CY2023Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
377000
CY2023Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
380000
CY2023Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
378000
CY2023Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter
DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
1732000
CY2023 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
133000
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
216000
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
230000
CY2023 us-gaap Restricted Stock Expense
RestrictedStockExpense
460000
CY2022 us-gaap Restricted Stock Expense
RestrictedStockExpense
916000
CY2021 us-gaap Restricted Stock Expense
RestrictedStockExpense
187000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
593000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1132000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
417000
CY2023 bcbp Stock Issued During Period Shares Cashless Stock Options Exercised
StockIssuedDuringPeriodSharesCashlessStockOptionsExercised
9628
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
48150
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.83
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
52252
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.01
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
13650
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
14.60
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
86752
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.98
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1194425
CY2021 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
9.02
CY2021 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.64
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y5M8D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4528000
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
157450
CY2022 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Exercised Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExercisedExercisePriceRangeLowerRangeLimit
9.03
CY2022 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Exercised Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExercisedExercisePriceRangeUpperRangeLimit
13.68
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
11.1
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1036975
CY2022 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
9.03
CY2022 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.72
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y5M19D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6502000
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
61000
CY2023 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Exercised Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExercisedExercisePriceRange
9.03
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.03
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
975975
CY2023 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
10.55
CY2023 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.89
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M29D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
984000
CY2022 bcbp Stock Issued During Period Shares Cashless Stock Options Exercised
StockIssuedDuringPeriodSharesCashlessStockOptionsExercised
84604
CY2023Q4 bcbp Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Underlying Unexercised Options
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnderlyingUnexercisedOptions
166480
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
272000
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y11M12D
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2023Q4 bcbp Minimum Percentage Of Capital Stock Surplus Under Dividend Restriction
MinimumPercentageOfCapitalStockSurplusUnderDividendRestriction
0.50
CY2023 us-gaap Cash Dividends Paid To Parent Company
CashDividendsPaidToParentCompany
20580000
CY2022 us-gaap Cash Dividends Paid To Parent Company
CashDividendsPaidToParentCompany
22338000
CY2021 us-gaap Cash Dividends Paid To Parent Company
CashDividendsPaidToParentCompany
15885000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
8917000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
12323000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
8736000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5592000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
6215000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
6257000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14509000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
18538000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14993000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1634000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-967000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-571000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-903000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-40000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-404000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2537000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1007000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-975000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11972000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17531000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14018000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
9805000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
9253000
CY2022Q4 bcbp Deferred Income Tax Assets Other Real Estate Owned Expenses
DeferredIncomeTaxAssetsOtherRealEstateOwnedExpenses
2000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
176000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
279000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
166000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
159000
CY2022Q4 bcbp Deferred Income Tax Assets Valuation Adjustment On Loans Receivable Acquired
DeferredIncomeTaxAssetsValuationAdjustmentOnLoansReceivableAcquired
752000
CY2023Q4 bcbp Deferred Tax Assets Operating Loss Carryforwards Net Of Valuation Adjustment
DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAdjustment
1166000
CY2022Q4 bcbp Deferred Tax Assets Operating Loss Carryforwards Net Of Valuation Adjustment
DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAdjustment
1263000
CY2023Q4 bcbp Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
3806000
CY2022Q4 bcbp Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
3961000
CY2023Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
2860000
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
2974000
CY2023Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
477000
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
66000
CY2023Q4 bcbp Deferred Fees And Costs
DeferredFeesAndCosts
1168000
CY2022Q4 bcbp Deferred Fees And Costs
DeferredFeesAndCosts
1348000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3002000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1369000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22626000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21426000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
71000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
74000
CY2023Q4 bcbp Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
3697000
CY2022Q4 bcbp Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
3865000
CY2023Q4 bcbp Deferred Income Tax Liabilities Sba Servicing Asset
DeferredIncomeTaxLiabilitiesSbaServicingAsset
319000
CY2022Q4 bcbp Deferred Income Tax Liabilities Sba Servicing Asset
DeferredIncomeTaxLiabilitiesSbaServicingAsset
368000
CY2023Q4 bcbp Deferred Income Tax Liabilities Borrowing Modification
DeferredIncomeTaxLiabilitiesBorrowingModification
282000
CY2022Q4 bcbp Deferred Income Tax Liabilities Borrowing Modification
DeferredIncomeTaxLiabilitiesBorrowingModification
440000
CY2023Q4 bcbp Deferred Income Tax Liabilities Defined Benefit Plans
DeferredIncomeTaxLiabilitiesDefinedBenefitPlans
44000
CY2022Q4 bcbp Deferred Income Tax Liabilities Defined Benefit Plans
DeferredIncomeTaxLiabilitiesDefinedBenefitPlans
217000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4413000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4964000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
18213000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
16462000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
16462000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
12959000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2537000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1007000
CY2023 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-355000
CY2022 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-2560000
CY2023 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
7000
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-64000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
18213000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
16462000
CY2018Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
8700000
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5600000
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6000000.0
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
8706000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
13253000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
10134000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3704000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
4878000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
4684000
CY2023 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
30000
CY2022 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
63000
CY2021 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
45000
CY2023 bcbp Income Tax Reconciliation Bank Owned Life Insurance Income
IncomeTaxReconciliationBankOwnedLifeInsuranceIncome
368000
CY2022 bcbp Income Tax Reconciliation Bank Owned Life Insurance Income
IncomeTaxReconciliationBankOwnedLifeInsuranceIncome
561000
CY2021 bcbp Income Tax Reconciliation Bank Owned Life Insurance Income
IncomeTaxReconciliationBankOwnedLifeInsuranceIncome
620000
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-40000
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
24000
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-135000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11972000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17531000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14018000
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.289
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.278
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.290
CY2023Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
313052000
CY2022Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
485050000
CY2021Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
269675000
CY2023 bcbp Number Of Operating Leases
NumberOfOperatingLeases
27
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
3591000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
3758000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
1056000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
1002000
CY2023 us-gaap Lease Cost
LeaseCost
4647000
CY2022 us-gaap Lease Cost
LeaseCost
4760000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12935000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13520000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3094000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3062000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11526000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12218000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1305000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1421000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13315000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13859000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M7D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y5M26D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y11M26D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0302
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0283
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0260
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3094000
CY2023Q4 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
5132000
CY2023Q4 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
3632000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2762000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14620000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1305000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13315000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
87769000
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
9093000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
96862000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
91715000
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
17686000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
109401000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
85186000
CY2021Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
25187000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
110373000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7491000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6491000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1128000
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001228454-24-000003-index-headers.html Edgar Link pending
0001228454-24-000003-index.html Edgar Link pending
0001228454-24-000003.txt Edgar Link pending
0001228454-24-000003-xbrl.zip Edgar Link pending
bcbp-20231231.xsd Edgar Link pending
bcbp-20231231x10k.htm Edgar Link pending
bcbp-20231231x10kg001.jpg Edgar Link pending
bcbp-20231231xex10_2.htm Edgar Link pending
bcbp-20231231xex21.htm Edgar Link pending
bcbp-20231231xex23.htm Edgar Link pending
bcbp-20231231xex31_1.htm Edgar Link pending
bcbp-20231231xex31_2.htm Edgar Link pending
bcbp-20231231xex32.htm Edgar Link pending
bcbp-20231231xex3_1.htm Edgar Link pending
bcbp-20231231xex97_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
bcbp-20231231_def.xml Edgar Link unprocessable
bcbp-20231231_lab.xml Edgar Link unprocessable
bcbp-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bcbp-20231231x10k_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bcbp-20231231_cal.xml Edgar Link unprocessable